Protocol for Standardized Diagnostic Procedures, Registration, and Treatment Recommendations in Children and Adolescents With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML).
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms CML-paed II
- 31 Aug 2018 Biomarkers information updated
- 28 Feb 2012 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
- 07 Jul 2011 Planned end date changed from 1 Mar 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.